-
Imo govt organises seminar for patent medicine dealers to fight illicit drug abuse
26 Apr 2025 14:02 GMT
… at a seminar organised for patent medicine dealers in Imo State … against abuse of illicit drugs.
Patent medicine dealers across Imo State … drug abuse.
For the Registrar pharmacy council of Nigeria, Ibrahim Ahmed …
-
How tariffs impact pharma stocks
25 Apr 2025 22:22 GMT
… recent report saying the US pharmaceutical tariffs would raise US drug … navigating how to play the pharmaceutical sector with the Yahoo Finance … you know, carve-out for pharma specifically, or, you know, … #39;s so many big patent expirations that start to poke …
-
CSPC Zhongqi Pharmaceutical Technology describes new EGFR degradation inducers
25 Apr 2025 20:57 GMT
Cancer
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. has … lung cancer.
BioWorld Science Cancer Patents
-
Big Pharmaâs blind spot: vitamin D slashes colon cancer riskâso why isnât it front-page news?
25 Apr 2025 21:26 GMT
Big Pharma’s blind spot: vitamin D … ? Vitamin D can’t be patented. Unlike blockbuster drugs, it’s … billion-dollar margins for Big Pharma. Even the U.S. Preventive … divert funding from nutrients to pharmaceuticals.”
Diet related behavior predicts colon …
-
New PARG inhibitors disclosed in Ideaya patent
25 Apr 2025 20:57 GMT
-
Insilico Medicine patents new CBLB inhibitors
25 Apr 2025 20:57 GMT
-
AKOS BIO Pharmacy is redefining medical cannabis access in South Africa
25 Apr 2025 20:57 GMT
… treatment plan, the pharmacy dispenses the appropriate medical … of clinicians and pharmacists — including a Responsible Pharmacist — supports … UNITAID, and the Medicines Patent Pool, helping to open … a fully licensed pharmacy — AKOS BIO Pharmacy ensures every …
-
Using IP strategy to maximise investability for pharma SMEs
25 Apr 2025 20:47 GMT
As Big Pharma moves to acquisitions to avoid pending patent cliffs, how can …
-
Addressing Patent Abuse, Reimbursement Models Key to Sustainable Biosimilar Market
25 Apr 2025 16:30 GMT
Streamlining regulatory processes, addressing patent abuse, and evolving reimbursement models to ensure sustainability can help overcome barriers and expand biosimilars into new therapeutic areas, according to Sonia T. Oskouei, PharmD, vice president of …
-
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
25 Apr 2025 14:54 GMT
… pharma’s subcutaneous Keytruda infringes 15 of its Mdase family of patents … 3,000 bottles of OCD medication in the US after subpar …